
What smart money is saying about Katakura Industries
1 fund in our archive has pitched Katakura Industries — most recently Goodhart Partners Global Real Return Fund in June 2026.
Katakura Industries Co., Ltd. is a diversified Japanese enterprise operating across multiple sectors including textiles, pharmaceuticals, machinery, real estate, and various consumer and life solutions. Its textile segment produces a wide array of apparel, from undergarments and hosiery to aprons and leisurewear, alongside advanced functional fibers such as water-soluble Solvron and thermal-resistant NITIVY ALF. In the pharmaceutical arena, the company develops and sells medications for cardiovascular conditions, notably Frandol and Frandol Tape for angina pectoris. The machinery division's offerings are extensive, covering environmental cleaning equipment, cutting oil products, fire engines and related apparatus, agricultural machinery, and automotive parts. Additionally, Katakura is involved in commercial property management, real estate development, and land leasing. Its broader 'life solutions' activities include agricultural and food products, nursing care equipment, general building maintenance, landscaping services, and the operation of specialty stores for plants and pets. Founded in 1873 as Katakura Silk Spinning Co., Ltd., the company adopted its present name in November 1943 and is headquartered in Tokyo, Japan.
Fund coverage · 1 thesis
Katakura Industries is a deep-value Japanese property and conglomerate play with a fortress balance sheet, valuable assets, and a large discount to NAV.
Read the full thesis
Read every full thesis on Katakura Industries
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→